tretinoin and Pituitary-Diseases

Bone morphogenetic protein-4 (BMP-4), a member of the transforming growth factor-Beta(TGF-Beta) family, is overexpressed in different prolactinoma models and induces the development of these lineage adenomas. SMAD proteins activated by growth factors of the TGF-Beta and BMP family interact with estrogen receptors to stimulate the proliferation of prolactin and growth hormone-secreting cells. Furthermore, BMP-4 presents differential expression in normal and adenomatous corticotropes and inhibitory action on corticotropinoma cell proliferation. Moreover, BMP-4 mediates the antiproliferative action of retinoic acid in these cells. The present review highlights not only the crucial and opposite role of BMP-4 in the progression of pituitary adenomas but also that BMP-4 and retinoic acid interaction might serve as a potential new mechanism target for therapeutic approaches for Cushing disease.

Topics: Adrenocorticotropic Hormone; Animals; Bone Morphogenetic Protein 4; Bone Morphogenetic Proteins; Gene Expression; Humans; Models, Biological; Neurons; Pituitary Diseases; Pituitary Gland; Receptors, Transforming Growth Factor beta; Transforming Growth Factor beta; Tretinoin